Annovis Bio (07X) Ownership - Who Owns Annovis Bio?
4 Followers
Annovis Bio (07X) Ownership Overview
- 11.28% Insiders
- 4.50% Mutual Funds
- 0.49% Other Institutional Investors
- 3.95% ETFs
- 79.77% Public Companies and Individual Investors
The ownership structure of Annovis Bio (DE:07X) stock is a mix of institutional, retail, and individual investors. Approximately 8.95% of the company’s stock is owned by Institutional Investors, 11.28% is owned by Insiders, and 79.77% is owned by Public Companies and Individual Investors.
The ownership structure of Annovis Bio (DE:07X) stock is a mix of institutional, retail, and individual investors. Approximately 8.95% of the company’s stock is owned by Institutional Investors, 11.28% is owned by Insiders, and 79.77% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 20, 2026 | Michael B. Hoffman | $142,235 | |
| Apr 02, 2026 | Michael B. Hoffman | $1,498,980 | |
| Dec 07, 2025 | Michael B. Hoffman | $193,500 | |
| Nov 24, 2025 | Michael B. Hoffman | $159,886 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Michael B. Hoffman | 3,588,240 | Insider | 8.41% | 3,904,005 |
| Vanguard Index Funds | 1,613,605 | Institution | 3.78% | 1,755,602 |
| Vanguard | 1,560,695 | Institution | 3.66% | 1,698,036 |
| Maria-luisa Maccecchini | 1,212,020 | Insider | 2.84% | 1,318,678 |
| BlackRock, Inc. | 249,856 | Institution | 0.59% | 271,843 |
| Fidelity Concord Street Trust | 240,030 | Institution | 0.56% | 261,153 |
| Ishares | 93,812 | Institution | 0.22% | 102,067 |
| Bridgeway Funds, Inc. | 33,577 | Institution | 0.08% | 36,532 |
| Bridgeway | 32,659 | Institution | 0.08% | 35,533 |
| Vanguard Valley Forge Funds | 20,994 | Institution | 0.05% | 22,841 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,613,605 | Institution | 3.78% | 1,755,602 |
| Fidelity Concord Street Trust | 240,030 | Institution | 0.56% | 261,153 |
| Bridgeway Funds, Inc. | 33,577 | Institution | 0.08% | 36,532 |
| Vanguard Valley Forge Funds | 20,994 | Institution | 0.05% | 22,841 |
| Vanguard Institutional Index Funds | 12,723 | Institution | 0.03% | 13,843 |
| Victory Portfolios Iii | 622 | Institution | <0.01% | 677 |
| John Hancock Variable Insurance Trust | 557 | Institution | <0.01% | 606 |
FAQ
Who Owns Annovis Bio (DE:07X)?
According to the latest TipRanks data, approximately 8.95% of the company's stock is held by institutional investors, 11.28% is held by insiders, and 79.77% is held by public companies and individual investors.
What percentage of Annovis Bio (DE:07X) stock is held by institutional investors?
According to the latest TipRanks data, approximately 8.95% of Annovis Bio (DE:07X) stock is held by institutional investors: 4.50% by mutual funds, 3.95% by ETFs and 0.49% by other institutional investors.
What percentage of Annovis Bio (DE:07X) stock is held by retail investors?
According to the latest TipRanks data, approximately 79.77% of Annovis Bio (DE:07X) stock is held by public companies and individual investors.
Who owns the most shares of Annovis Bio (DE:07X)?
Michael B. Hoffman owns the most shares of Annovis Bio (DE:07X).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
